QUOTED. March 07, 2019. Mark Day
Executive Summary
Electrocardiography (ECG) trial data by iRhythm Technologies Inc.'s Zio ambulatory continuous-care wearable ECG monitor analyzed by artificial intelligence showed that it can detect cardiac arrhythmias as effectively as a panel of expert cardiologists. See what iRhythm's EVP for R&D Mark Day said about it here.
"Two weeks represents about 1.5 million heartbeats, but a patients’ arrhythmia may only appear in as few as 10 of those heartbeats.That's a problem that AI is really well suited to address." – Mark Day, Executive Vice President of Research & Development, iRhythm
Click here for a free trial of Medtech Insight